Recombinant CD79B (Polatuzumab Biosimilar) antibody

Catalog No. ABIN7597917

This Humanized Chimeric antibody specifically detects CD79B (Polatuzumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD79B (Polatuzumab Biosimilar) antibody (ABIN7597917)

Target: CD79B (Polatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD79B (Polatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Polatuzumab Biosimilar Antibody

Specificity: B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD79B (Polatuzumab Biosimilar)

Target: CD79B (Polatuzumab Biosimilar)

Alternative Name: Polatuzumab Biosimilar

Target Type: Biosimilar

Background: B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b

UniProt: P40259

CAS-No: 1313206-42-6